Found: 23
Select item for more details and to access through your institution.
A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 2, p. n/a, doi. 10.1002/prp2.113
- By:
- Publication type:
- Article
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- clinical trial
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8<sup>+</sup> T-cell responses in melanoma patients.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 11, p. 3049, doi. 10.1002/eji.201142361
- By:
- Publication type:
- Article
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 609, doi. 10.1007/s11912-023-01385-6
- By:
- Publication type:
- Article
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 11, p. 1, doi. 10.1007/s11912-018-0732-8
- By:
- Publication type:
- Article
Merkel cell carcinoma in situ: A systematic review of prognosis and management.
- Published in:
- Australasian Journal of Dermatology, 2022, v. 63, n. 1, p. e6, doi. 10.1111/ajd.13758
- By:
- Publication type:
- Article
Noncutaneous Melanomas: A Single-Center Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139438
- By:
- Publication type:
- Article
RASopathic Skin Eruptions during Vemurafenib Therapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058721
- By:
- Publication type:
- Article
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053745
- By:
- Publication type:
- Article
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 765, doi. 10.1007/s00262-019-02311-1
- By:
- Publication type:
- Article
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 8, p. 1904, doi. 10.1002/cam4.1140
- By:
- Publication type:
- Article
Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta‐analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 1, p. 1, doi. 10.1111/exd.14978
- By:
- Publication type:
- Article
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
- Published in:
- Genome Biology, 2015, v. 16, n. 1, p. 42, doi. 10.1186/s13059-015-0594-4
- By:
- Publication type:
- Article
To B-(RAF) or Not to Be.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 5, p. 1200, doi. 10.1038/jid.2014.62
- By:
- Publication type:
- Article
Cutaneous Lymphomas: Molecular Pathways Leading to New Drugs.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 3 part 1, p. 517, doi. 10.1038/jid.2011.370
- By:
- Publication type:
- Article
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Histological evaluation of a 'residual' metastasis after ipilimumab therapy in a patient with advanced melanoma.
- Published in:
- Journal of Dermatology, 2015, v. 42, n. 9, p. 927, doi. 10.1111/1346-8138.12964
- By:
- Publication type:
- Article
Long‐Term Response to Intermittent Binimetinib in Patients with NRAS‐Mutant Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1593, doi. 10.1634/theoncologist.2019-0656
- By:
- Publication type:
- Article
Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 749, doi. 10.1634/theoncologist.2016-0366
- By:
- Publication type:
- Article
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies.
- Published in:
- Pigment Cell & Melanoma Research, 2019, v. 32, n. 4, p. 553, doi. 10.1111/pcmr.12775
- By:
- Publication type:
- Article
Aktuelle Therapie des Melanoms der Haut.
- Published in:
- Therapeutische Umschau, 2010, v. 67, n. 9, p. 447, doi. 10.1024/0040-5930/a000078
- By:
- Publication type:
- Article